Guardant Health (GH) Net Income towards Common Stockholders (2017 - 2026)
Guardant Health's Net Income towards Common Stockholders history spans 9 years, with the latest figure at -$128.5 million for Q4 2025.
- On a quarterly basis, Net Income towards Common Stockholders fell 15.75% to -$128.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$416.3 million, a 4.61% increase, with the full-year FY2025 number at -$416.3 million, up 4.61% from a year prior.
- Net Income towards Common Stockholders hit -$128.5 million in Q4 2025 for Guardant Health, down from -$92.7 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for GH hit a ceiling of -$72.8 million in Q2 2023 and a floor of -$229.4 million in Q2 2022.
- Historically, Net Income towards Common Stockholders has averaged -$119.6 million across 5 years, with a median of -$108.7 million in 2021.
- Biggest five-year swings in Net Income towards Common Stockholders: plummeted 295.46% in 2021 and later skyrocketed 68.28% in 2023.
- Tracing GH's Net Income towards Common Stockholders over 5 years: stood at -$90.9 million in 2021, then tumbled by 53.92% to -$139.9 million in 2022, then plummeted by 33.67% to -$187.0 million in 2023, then soared by 40.65% to -$111.0 million in 2024, then decreased by 15.75% to -$128.5 million in 2025.
- Business Quant data shows Net Income towards Common Stockholders for GH at -$128.5 million in Q4 2025, -$92.7 million in Q3 2025, and -$99.9 million in Q2 2025.